Optimizing Treatment Response: Insights from Clinical Data and Real-World Experience

Gus Alva, MD, DFAPA; Carmen Kosicek, MSN, PMHNP-BC; and Roger McIntyre, MD, FRCPC wrap up the conversation discussing optimizing treatment response with a focus on rapid-acting antidepressants (ADTs), including real-world patient responses and clinical study data. They address patient education, treatment expectations, titration, and follow-up strategies to enhance treatment optimization and outcomes.

EP: 1.Expert Insights into Navigating MDD Prevalence, Stigma, and Treatment Challenges for Improved Patient Outcomes

EP: 2.Advancing MDD Treatment: From STAR*D Insights to Precision Medicine and Novel Therapeutics

EP: 3.Commentary on Redefining Depression Management with Updated Treatment Strategies

EP: 4.Navigating Non-Response: A Holistic Approach to Patient Care

EP: 5.Transforming MDD: A Patient's Journey with Rapid-Acting Therapy

EP: 6.Quantifying Success: Measuring Depth of Treatment Response in MDD

EP: 7.Access Challenges: Bridging Insurance Gaps for MDD Innovations

EP: 8.Depression Treatment: Expert Guide to Medication Management & Therapeutic Success

EP: 9.From Neuroplasticity to Patient Conversations: Managing Affective Disorders Effectively

EP: 10.Managing Persistent MDD: Case Studies and Treatment Challenges

EP: 11.Evaluating Treatment Failure and Symptomatic Remission in MDD

EP: 12.Exploring Rapid-Acting Therapies in MDD: Pharmacodynamics and Treatment Evolution

EP: 13.Addressing Unsatisfactory Responses in Chronic MDD

EP: 14.Defining and Managing Treatment-Resistant Depression: Efficacy and Real-World Insights

Now Viewing